NO DECISIONDismissed90% confidenceGrok 4.20 (xAI)
Question
Will this trial meet its primary endpoint?
Found
Reviewed
Summary
Trial ongoing (active, not recruiting). Estimated primary completion Sep 2026. No results or readout posted on GSK register or ClinicalTrials.gov.
Sources
Web Searchgsk-studyregister.com
GSKTrial ID 219867
Study results yet to be posted. Status: active, not recruiting. Primary completion: 2026-09-30.
Web Searchclinicaltrials.gov
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease (PROGRESS-AD)
Active, not recruiting. Estimated primary completion: 2026-09-30. No study results available.